As of January 2026 Lyell Immunopharma has a market cap of NZ$1.13 Billion. This makes Lyell Immunopharma the world's 6718th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 1st, 2026 the market cap of Lyell Immunopharma was reported to be: